BioNTech/CureVac: German court voids CureVac patent after BioNTech challenge, stock drops 41%
birdflustocks.com » bird flu stocks  »  BioNTech/CureVac: German court voids CureVac patent after BioNTech challenge, stock drops 41%
BioNTech/CureVac: German court voids CureVac patent after BioNTech challenge, stock drops 41%

https://www.maucherjenkins.com/commentary/first-instance-declares-german-curevac-patent-on-mrna-vaccine-against-covid-19-invalid